Industry News, Trustworthy Insights

Popular Companies:

Jefferies, Goldman Sachs: Advisory on $627M GTCR Acquisition Explained

Jefferies and Goldman Sachs are advising on GTCR’s $627 million acquisition of Surmodics.

Jefferies headquarters in New York, US, PHOTO: Getty Images
Jefferies headquarters in New York, US, PHOTO: Getty Images

Surmodics, a leading provider of surface modification technologies for medical devices and chemical components for in vitro diagnostics. This deal offers Surmodics’ shareholders a substantial premium, reflecting the company’s achievements and progress. Surmodics President and CEO Gary Maharaj emphasized that GTCR is an ideal partner due to its extensive healthcare sector expertise.

GTCR will acquire all outstanding shares of Surmodics for $43.00 per

Industry news used by professionals

Try £4.99 per month

Already a member?
Weekly Digest

All the week’s industry events straight to your inbox.

Before your sign up, please read terms of use and privacy policy.

Trending

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to our terms of use and privacy policy.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Password Reset

You will soon receive a Reset Password link

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to terms of use and privacy policy.

Send us your article

popup

Maximum file size: 2.1MB

Start Over